US Patent 9242961 Aurora kinase modulators and method of use

Patent 9242961 was granted and assigned to Amgen on January, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Amgen

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92429610

Patent Inventor Names

Karina Romero0

Victor J. Cee0

Date of Patent

January 26, 2016

Patent Application Number

140457150

Date Filed

October 3, 2013

Patent Citations Received

‌

US Patent 11925651 TEAD inhibitors and uses thereof

‌

US Patent 11760728 Tead inhibitors and uses thereof

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention relates to chemical compounds having a general formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9242961 Aurora kinase modulators and method of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API